000 01359nam a2200349Ia 4500
001 EBC3050156
003 MiAaPQ
005 20240121042130.0
006 m o d |
007 cr cn|||||||||
008 040926s2003 sz gsb 000 0 spa d
020 _z9243209159
035 _a(MiAaPQ)EBC3050156
035 _a(Au-PeEL)EBL3050156
035 _a(CaPaEBR)ebr10062382
035 _a(OCoLC)927460587
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aRM315
_b.C66 2003
110 2 _aWHO Expert Committee on Addiction-Producing Drugs.
245 1 0 _aComite de Expertos de los OMS en Farmacodependencia
_h[electronic resource] :
_b33o informe /
_cOrganizacion Mundial de la Salud.
260 _aGinebra :
_bOrganizacion Mundial de la Salud,
_c2003.
300 _av, 28 p.
490 1 _aOMS, serie de informes tecnicos ;
_v915
504 _aIncludes bibliographical references.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aPsychotropic drugs.
650 0 _aDrugs.
655 4 _aElectronic books.
710 2 _aProQuest (Firm)
830 0 _aTechnical report series (World Health Organization) ;
_v915.
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3050156
_zClick to View
999 _c163313
_d163313